MAX and neuroblastoma: This data makes us believe that MAX is one the late effectors SH-SY5Y differentiation, suggesting that its expression is implicated in favorable outcomes for MYCN non-amplified neuroblastoma patients by means of enhancing cell differentiation and/or impairing proliferation.